ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Figure Left unchanged By Carter; Pay Raise Puts further Squeeze On Institute Budget

March 4, 1977

In Brief: NCI Rushing To Complete Development Of Program Grants System By June 30

May 17, 1974

New System Devised To Help Identify Emerging Comprehensive Centers

October 10, 1975

NCI Seeks Health Care Provider Groups To Form Cancer Control Research Network

September 12, 1997

Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions

September 27, 1996

Bush Appoints Lander To NCAB

January 24, 2003